|
TikosynDrug - Tikosyn The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Dofetilide
Strength -
0.125MG
Applicant -
PFIZER
New Drug Application (NDA) Number -
020931
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Oct 1, 1999
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Pfizer Pharmaceuticals Production Corp Ltd
Tikosyn
Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 400mg Base/100ml Injectable; Injection
Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 50mg Base/100ml Injectable; Injection Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 100mg Base/100ml Injectable; Injection Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 200mg Base/100ml Injectable; Injection Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 400mg Base/100ml Injectable; Injection Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 50mg Base/100ml Injectable; Injection Dobutrex Eq 12.5mg Base/ml Injectable; Injection Taxotere Eq 40mg Base/ml Injectable; Injection Abreva 10% Cream; Topical Tikosyn 0.125mg Capsule; Oral NewDrugInformation |